Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Keros Therapeutics (KROS) Shares Outstanding: 2019-2025

Historic Shares Outstanding for Keros Therapeutics (KROS) over the last 7 years, with Sep 2025 value amounting to $40.6 million.

  • Keros Therapeutics' Shares Outstanding rose 3.50% to $40.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.6 million, marking a year-over-year increase of 3.50%. This contributed to the annual value of $40.6 million for FY2024, which is 27.37% up from last year.
  • Per Keros Therapeutics' latest filing, its Shares Outstanding stood at $40.6 million for Q3 2025, which was up 0.04% from $40.6 million recorded in Q2 2025.
  • In the past 5 years, Keros Therapeutics' Shares Outstanding registered a high of $40.6 million during Q3 2025, and its lowest value of $23.3 million during Q1 2021.
  • In the last 3 years, Keros Therapeutics' Shares Outstanding had a median value of $36.2 million in 2024 and averaged $35.9 million.
  • Data for Keros Therapeutics' Shares Outstanding shows a peak YoY surged of 833.97% (in 2021) over the last 5 years.
  • Over the past 5 years, Keros Therapeutics' Shares Outstanding (Quarterly) stood at $24.0 million in 2021, then grew by 14.88% to $27.5 million in 2022, then grew by 15.60% to $31.8 million in 2023, then rose by 27.37% to $40.6 million in 2024, then grew by 3.50% to $40.6 million in 2025.
  • Its Shares Outstanding was $40.6 million in Q3 2025, compared to $40.6 million in Q2 2025 and $40.6 million in Q1 2025.